When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MEIP - MEI Pharma on license deal for blood cancer candidate
MEI Pharma Inc.
MEI Pharma (NASDAQ:MEIP) jumps 77% premarket on robust volume in reaction to its agreement with Kyowa Kirin Co., Ltd. (OTCPK:KYKOF) to co-develop and co-promote Phase 2-stage ME-401 in the U.S. for the treatment of B-cell blood cancers.
More news on: MEI Pharma, Inc., Kyowa Kirin Co., Ltd., Healthcare stocks news, Stocks on the move,